Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: Systematic review and meta-analysis

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1162-1170

  Kunutsor, Setor K ^a   Apekey, Tanefa A ^b   Van Hemelrijck, Mieke ^c   Calori, Giliola ^d   Perseghin, Gianluca ^e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LEEDS TRINITY UNIVERSITY   (United Kingdom)

^c Department of Rheumatology School of Medicine   (United Kingdom)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Alanine aminotransferase; Cancer; Gamma glutamyltransferase; Meta analysis

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ASIAN; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DIGESTIVE SYSTEM CANCER; EUROPEAN; FEMALE; FEMALE GENITAL TRACT CANCER; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; MALE GENITAL TRACT CANCER; META ANALYSIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RESPIRATORY TRACT CANCER; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; FOLLOW UP; INCIDENCE; METABOLISM; NEOPLASMS; PROGNOSIS;

ALANINE TRANSAMINASE; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 84918812861     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29084     Document Type: Review

References (50)

1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
2. Wroblewski F, Ladue JS. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med 1956;91:569-71.
3. Fraser A, Harris R, Sattar N, et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009;32:741-50.
4. Kunutsor SK, Apekey TA, Walley J. Liver Aminotransferases and Risk of Incident Type 2 Diabetes: a Systematic Review and Meta-Analysis. Am J Epidemiol 2013. doi: 10.1093/aje/kws469.
5. Fraser A, Harris R, Sattar N, et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007;27:2729-35.
6. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007;191:391-6.
7. Ruttmann E, Brant LJ, Concin H, et al. Gammaglutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163, 944 Austrian adults. Circulation 2005;112:2130-7.
8. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004;328:983.
9. Kunutsor S, Apekey TA, Seddoh D, et al. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol 2014;43:187-201.
10. Van Hemelrijck M, Jassem W, Walldius G, et al. Gamma-glutamyltransferase and risk of cancer in a cohort of 545, 460 persons-the Swedish AMORIS study. Eur J Cancer 2011;47:2033-41.
11. Strasak AM, Rapp K, Brant LJ, et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 2008;68:3970-7.
12. Koehler EM, Sanna D, Hansen BE, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int 2014;34:296-304.
13. Ford I, Mooijaart SP, Lloyd S, et al. The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol 2011;40:1530-8.
14. Breitling LP, Claessen H, Drath C, et al. Gamma-glutamyltransferase, general and causespecific mortality in 19, 000 construction workers followed over 20 years. J Hepatol 2011;55:594-601.
15. Calori G, Lattuada G, Ragogna F, et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011;54:145-52.
16. Long Y, Zeng F, Shi J, et al. Gamma-glutamyltransferase predicts increased risk of mortality: a systematic review and meta-analysis of prospective observational studies. Free Radic Res 2014;48:716-28.
17. Stroup DF, Berlin JA, Morton SC, et al.; Group ftM-aOOSiE. Meta-analysis of observational studies in epidemiology. JAMA 2000;283:2008-12.
18. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
19. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses, 2011. www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
20. Chéne G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 1996;144:610-21.
21. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
22. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
23. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006;6:40-57.
24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
25. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999;18:2693-708.
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
27. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
28. Poole C, Greenland S. Random-effects metaanalyses are not always conservative. Am J epidemiol 1999;150:469-75.
29. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63.
30. Pompella A, Corti A, Paolicchi A, et al. Gammaglutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 2007;7:360-6.
31. Franzini M, Corti A, Lorenzini E, et al. Modulation of cell growth and cisplatin sensitivity by membrane gammaglutamyltransferase in melanoma cells. Eur J Cancer 2006;42:2623-30.
32. Hanigan MH, Gallagher BC, Townsend DM, et al. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 1999;20:553-9.
33. Brownlee M. Negative consequences of glycation. Metabolism 2000;49:9-13.
34. Lee DH, Jacobs DR, Jr. Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase: results from the National Health and Examination Survey 1999-2002. Clin Chem 2006;52:1825-7.
35. Lee DH, Lim JS, Song K, et al. Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U. S. population: results from the third National Health and Nutrition Examination Survey. Environmental health perspectives 2006;114:350-4.
36. Seitz HK, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health 2007;30:38-41, 4-7.
37. Cho E, Smith-Warner SA, Ritz J, et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 2004;140:603-13.
38. Breitling LP, Raum E, Muller H, et al. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009;49:802-8.
39. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006;12:1175-81.
40. Tsuboya T, Kuriyama S, Nagai M, et al. Gamma-glutamyltransferase and cancer incidence: the Ohsaki cohort study. J Epidemiol 2012;22:144-50.
41. Musso G, Gambino R, Cassader M, et al. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 2010;52:79-104.
42. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
43. Rahmioglu N, Andrew T, Cherkas L, et al. Epidemiology and genetic epidemiology of the liver function test proteins. PLoS ONE 2009;4:e4435.
44. Yuan X, Waterworth D, Perry JR, et al. Populationbased genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008;83:520-8.
45. Conen D, Vollenweider P, Rousson V, et al. Use of a Mendelian randomization approach to assess the causal relation of gamma-glutamyltransferase with blood pressure and serum insulin levels. Am J Epidemiol 2010;172:1431-41.
46. Kunutsor SK, Apekey TA, Khan H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies Atherosclerosis 2014. http://dx.doi.org/10.1016/j.atherosclerosis.2014.06.006.
47. Zambon P, Talamini R, La Vecchia C, et al. Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy. Int J Cancer 2000;86:144-9.
48. Rusu E, Jinga M, Enache G, et al. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C-a randomized trial. Nutr J 2013;12:119.
49. Suzuki A, Lindor K, St Saver J, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060-6.
50. Demers PA, Vaughan TL, Checkoway H, et al. Cancer identification using a tumor registry versus death certificates in occupational cohort studies in the United States. Am J Epidemiol 1992;136:1232-40.